US Physical Therapy Stock (NYSE:USPH), Trade Ideas

US Physical Therapy

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AMBO

APGN

BDRX

BIOL

CRMT

CWBR

DRMA

EEIQ

ENVB

EXPR

GTEC

HSAI

HTCR

HYLN

IDAI

IVVD

KINS

KMDA

NAVB

NFTG

NVTS

OCEA

OCGN

OPRX

ORGO

PANW

PHGE

PLAB

PLCE

PTCT

QBTS

QTEK

iShares FTSE NAREIT Retail Capped Index Fund

SMFL

SPCE

SRPT

TTOO

UFAB

URBN

USPH

UTRS

VIRI

WOOF

XPEV

ZURA

Gainers


	Minerva Surgical, Inc.  (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.


Why America&#39;s Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Earnings

Pre-Market Outlook

AINC

ALNA

AMPE

AMST

AMTD

APDN

AREB

ARIS

ATTO

ATUS

BALL

BCRX

BNTC

CCXI

CNET

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

COIN

CROX

CUEN

DBGI

ECPG

ECVT

EGHT

ELOX

FRGE

FSLY

FTNT

GOVX

GRNA

GRNQ

HSCS

HSDT

IMUX

INFU

INSM

ITRI

KSPN

LCID

LEGH

LFLY

LQDT

LXEH

MDIA

MELI

MHUA

MSPR

NERV

NNVC

NVIV

PAGS

PGEN

PRFT

QNRX

RCII

RVLV

SITM

SOPA

STAF

SYRS

TMBR

TNDM

TTMI

UFCS

VAPO

Gainers


	ChemoCentryx, Inc.  (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.


Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday

CSGS

GETY

LSPD

NTLA

OPEN

PDCE

YETI

 
	AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days.
	


Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday

US Physical Therapy Inc

U.S. Physical Therapy, Inc. (&quot;USPH&quot; or the &quot;Company&quot;) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with nine clinic locations.
USPH acquired a&nbsp;50%&nbsp;equity interest in the practice for a purchase price of&nbsp;$16.4 million, with the current practice owners retaining a&nbsp;50%&nbsp;interest. The business currently generates approximately&nbsp;$11.4 million&nbsp;in annual revenues and approximately 65,000 annual visits.

US Physical Therapy Announces Acquisition of a 50% Stake in Nine-Clinic Physical Therapy And Hand Therapy Practice for $16.4M

Revealing a significant insider sell on March 14, Carey Hendrickson, Chief Financial Officer at US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>), as per the latest SEC filing.
What Happened: After conducting a thorough analysis, Hendrickson sold 1,800 shares of US Physical Therapy. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000885978/000095017024031674//Archives/edgar/data/885978/000095017024031674/0000950170-24-031674-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total transaction value is $193,103.
US Physical Therapy's shares are actively trading at $106.55, experiencing a down of 0.0% during Friday's morning session.
<h3>Unveiling the Story Behind US Physical Therapy</h3>
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
<h3>Understanding the Numbers: US Physical Therapy's Finances</h3>
Revenue Growth: Over the 3 months period, US Physical Therapy showcased positive performance, achieving a revenue growth rate of 9.65% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 19.71%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): US Physical Therapy's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.38.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.54.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: US Physical Therapy's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 83.24.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 2.5 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 23.01, US Physical Therapy demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Transaction Codes To Focus On</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000885978">Check Out The Full List Of US Physical Therapy's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Chief Financial Officer Of US Physical Therapy Makes $193K Sale

JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) with a Overweight and raises the price target from $99 to $117.

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $117

&nbsp;The Change In Rate Is Not Retroactive To January 1, 2024

Health Care

General

U.S. Physical Therapy Announces Change In Medicare Rate Reduction For Remainder Of 2024; As A Result, The Company Estimates That Medicare Rate Reduction Effective March 9, 2024, Will Be Approximately 1.8% Rather Than 3.5%

Friday marks the last chance for investors to receive the next dividend payout from US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>). 
<h3>What's Happening</h3>
The company announced on Tuesday that it would pay shareholders a quarterly dividend of 44 cents per share. On Monday, US Physical Therapy will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 44 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own USPH as of the end of Friday's session are eligible to receive the 44 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on April 05, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on US Physical Therapy's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Dividends

US Physical Therapy's Ex-Dividend Date Is Monday, Here's What You Need To Know

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) with a Outperform and raises the price target from $120 to $122.

Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $122

US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.57 by 3.51 percent. This is a 1.72 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $154.80 million which beat the analyst consensus estimate of $150.27 million by 3.02 percent. This is a 9.65 percent increase over sales of $141.18 million the same period last year.

Earnings Beats

US Physical Therapy Q4 2023 Adj EPS $0.59 Beats $0.57 Estimate, Sales $154.80M Beat $150.27M Estimate